Rehmann Capital Advisory Group boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 50.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,642 shares of the healthcare conglomerate's stock after purchasing an additional 2,897 shares during the quarter. Rehmann Capital Advisory Group's holdings in UnitedHealth Group were worth $2,696,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently bought and sold shares of UNH. Brighton Jones LLC grew its holdings in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its stake in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares during the period. GAMMA Investing LLC grew its stake in UnitedHealth Group by 7.4% during the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate's stock worth $8,295,000 after buying an additional 1,089 shares during the period. Walkner Condon Financial Advisors LLC grew its stake in UnitedHealth Group by 4.2% during the first quarter. Walkner Condon Financial Advisors LLC now owns 890 shares of the healthcare conglomerate's stock worth $466,000 after buying an additional 36 shares during the period. Finally, Foundation Wealth Management LLC PA lifted its position in shares of UnitedHealth Group by 6.9% during the first quarter. Foundation Wealth Management LLC PA now owns 1,765 shares of the healthcare conglomerate's stock worth $925,000 after purchasing an additional 114 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Up 0.3%
UNH stock opened at $365.47 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a fifty day moving average price of $333.70 and a two-hundred day moving average price of $341.28. The firm has a market cap of $331.00 billion, a price-to-earnings ratio of 15.83, a PEG ratio of 2.36 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
Analyst Ratings Changes
UNH has been the topic of a number of recent research reports. Mizuho boosted their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an "outperform" rating in a research report on Thursday, October 9th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research report on Friday, September 12th. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an "overweight" rating in a report on Tuesday, October 7th. Truist Financial upped their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a report on Tuesday, September 9th. Finally, UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $385.13.
Read Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.